Cart
sales@molnova.com
Scio-323
CAS No. 309913-51-7
Scio-323( —— )
Catalog No. M36224 CAS No. 309913-51-7
Scio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 206 | In Stock |
|
| 5MG | 172 | In Stock |
|
| 10MG | 254 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 531 | In Stock |
|
| 100MG | 710 | In Stock |
|
| 200MG | 958 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameScio-323
-
NoteResearch use only, not for human use.
-
Brief DescriptionScio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.
-
DescriptionScio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number309913-51-7
-
Formula Weight479.54
-
Molecular FormulaC27H30FN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(N(C)C)=O)(=O)C=1C=2C(=CC(OC)=C(C(=O)N3CCC(CC4=CC=C(F)C=C4)CC3)C2)N(C)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SM1-71
SM1-71 is a potent multi-targeted acrylamide-modified TAK1 inhibitor that inhibits MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2.
-
TA-02
A potent p38 MAPK inhibitor with IC50 of 20 nM.
-
Cot inhibitor-1
Cot inhibitor-1 is a selective inhibitor of Cot protein kinase (also known as Tpl2 or MAP3K8) (IC50 at 28 nM). Cot inhibitor-1 inhibited TNF-alpha production in human whole blood with IC50 of 5.7 nM.
